| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.43 | 0.006 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |